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Reproductive function is driven by the hormonal interplay between the gonads and brain-pituitary 17 
axis. Gonadotropin-releasing hormone (GnRH) is released in a pulsatile manner, which is critical 18 
for the attainment and maintenance of fertility, however, GnRH neurons lack the ability to directly 19 
respond to most regulatory factors, and a hierarchical upstream neuronal network governs its 20 
secretion. We and others proposed a model in which Kiss1 neurons in the arcuate nucleus (ARC), 21 
so called KNDy neurons, release kisspeptin (a potent GnRH secretagogue) in a pulsatile manner 22 
to drive GnRH pulses under the coordinated autosynaptic action of its cotransmitters, the 23 
tachykinin neurokinin B (NKB, stimulatory) and dynorphin (inhibitory). Numerous genetic and 24 
pharmacological studies support this model; however, additional regulatory mechanisms 25 
(upstream of KNDy neurons) and alternative pathways of GnRH secretion (kisspeptin-26 
independent) exist, but remain ill defined. In this aspect, attention to other members of the 27 
tachykinin family, namely substance P (SP) and neurokinin A (NKA), has recently been rekindled. 28 
Even though there are still major gaps in our knowledge about the functional significance of these 29 
systems, substantial evidence, as discussed below, is placing tachykinin signaling as an important 30 
pathway for the awakening of the reproductive axis and the onset of puberty to physiological 31 
GnRH secretion and maintenance of fertility in adulthood. 32 
Introduction 33 
Successful production of offspring is indispensable to perpetuate species. As such, reproduction 34 
is under the control of a complex regulatory network which involves the hypothalamic-pituitary-35 
gonad (H-P-G) axis. Gonadotropin-releasing hormone (GnRH) neurons, located in the 36 
hypothalamus are a major component of the H-P-G axis and the ultimate regulators of 37 
reproductive function, including sexual behavior (Herbison 2016, Herbison, et al. 2008, Moenter, 38 
et al. 2003). Importantly, GnRH release is pulsatile, and even though GnRH neurons may display 39 
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autonomous activity (spontaneous bursts), these do not seem to correlate with GnRH/LH pulses 40 
in vivo [reviewed in (Navarro 2012)]. Furthermore, GnRH neurons lack the ability to sense most 41 
factors that influence reproductive function, such as endogenous signals [e.g. sex steroid 42 
hormones; (Hrabovszky and Liposits 2013, Radovick, et al. 2012, Roa 2013)] as well as 43 
environmental cues [e.g. stressors; (Dobson, et al. 2003)]. Thus, a large body of research is now 44 
focusing on the discovery of higher hierarchy circuits and their efficacy in stimulating GnRH 45 
secretion in to the hypophyseal portal vessels, thereby enabling gonadotropin [luteinizing 46 
hormone (LH) and follicle stimulating hormone (FSH)] secretion from the anterior pituitary in to 47 
the peripheral circulation. From then on, LH and FSH reach the gonads to stimulate 48 
gametogenesis and sex steroid production. In turn, sex steroids exert positive and negative 49 
feedback effects on pituitary and hypothalamic target cells (Herbison 1998), completing the H-P-50 
G axis. In this respect, over the past 10 years, several upstream neurophenotypes have been 51 
implicated in stimulatory and/or inhibitory regulation of GnRH secretion. 52 
The path was initially paved with the discovery that loss-of-function mutations in several 53 
neuroendocrine genes, including KISS1 and its receptor, KISS1R (Table 1), have been described 54 
to cause hypogonadotropic hypogonadism in humans (Chan, et al. 2011, de Roux, et al. 2003, 55 
Seminara, et al. 2003, Topaloglu, et al. 2012) due to a central deficit that leads to absent GnRH/LH 56 
pulses, highlighting the importance of these neural cues in GnRH release. Further anatomical and 57 
functional studies provided unequivocal evidence that kisspeptins, encoded by the Kiss1 gene 58 
(Table 1), are the most potent secretagogues of GnRH in all mammals studied to date (Oakley, 59 
et al. 2009). A number of studies by our lab and others suggest that Kiss1 neurons – which contact 60 
GnRH neurons directly - receive profuse central and peripheral regulatory inputs that modulate 61 
kisspeptin secretion for the initiation of puberty and the maintenance of fertility in adulthood 62 
(Pinilla, et al. 2012, Seminara, et al. 2003). Importantly, Kiss1 neurons also play a critical role in 63 
conveying information about the sex steroid milieu to GnRH neurons (Gill, et al. 2010, Navarro, 64 
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et al. 2004). However, kisspeptin action on GnRH neurons is necessary but not sufficient for the 65 
proper activation of GnRH neurons (Leon, et al. 2016). 66 
The development of newer, more potent and less expensive tools to screen genome sequences 67 
of affected patients is revealing a growing number of factors that appear critical for the timing of 68 
puberty onset and maintenance of fertility by regulating kisspeptin and/or GnRH/LH release. 69 
Within this constellation of neuroendocrine systems, is the one comprised by the tachykinin 70 
neurokinin B (NKB) and its receptor (NK3R), encoded by TAC3 and TACR3 in humans, 71 
respectively (Table 1). This system has received substantial attention since the identification in 72 
2009 of inactivating mutations in these genes are also associated with hypogonadotropic 73 
hypogonadism and lack of puberty onset (Topaloglu, et al. 2009, Topaloglu, et al. 2012, Yang, et 74 
al. 2012, Young, et al. 2010), resembling the phenotype of KISS1/KISS1R null patients. Moreover, 75 
the systemic administration of an NK3R antagonist (ESN364) in OVX ewes, castrated or cycling 76 
nonhuman primates as well as healthy men and women (Fraser, et al. 2015, Fraser, et al. 2016) 77 
show a partial inhibition of the reproductive axis. Indeed, numerous follow-up animal studies, 78 
confirmed that NKB is a critical stimulatory input to the GnRH network, in various species 79 
(Goodman, et al. 2014, Navarro 2013) although, interestingly, this stimulatory effect is not 80 
observed in healthy men (Narayanaswamy, et al. 2016), probably due to their circulating sex 81 
steroid levels as discussed below. However, unlike kisspeptin deficiency, the phenotype of 82 
patients lacking NKB signaling is less severe since reversal cases have been documented, in 83 
which some patients recovered reproductive function and fertility after delayed puberty (Gianetti, 84 
et al. 2010). A similar subfertile phenotype has been observed in genetically modified mouse 85 
models, where Tac2 and Tacr3 (encoding NKB and NK3R, respectively, in rodents, Table 1) had 86 
been deleted from the genome (Steiner and Navarro 2012, True, et al. 2015, Yang, et al. 2012). 87 
Therefore, it appears that the reversal phenotype in reproductive viability observed in human 88 
5 
 
individuals with TAC3/TACR3 or rodents with Tac2/Tacr3 mutations may be due to compensation 89 
by other neuronal systems.  90 
Interestingly, NKB is a member of the broader tachykinin family, which has the common C-91 
terminal sequence of Phe-X-Gly-Leu-Met-NH2 (Maggio 1988). This family also includes 92 
substance P (SP), neurokinin A (NKA), neuropeptide K (NPK), and neuropeptide γ (NPγ) (Otsuka 93 
and Yoshioka 1993, Page 2005). The vast majority of research has focused on SP, NKA and NKB 94 
which bind preferentially to the NK1R, NK2R and NK3R G-protein coupled receptors, respectively 95 
(Maggi 1995, Patacchini and Maggi 2001, Saffroy, et al. 2003). 96 
 Early studies documented a robust stimulatory action of LH release by SP in rats, rabbits and 97 
humans (Arisawa, et al. 1990, Coiro, et al. 1992, Kalra, et al. 1992, Sahu and Kalra 1992, Traczyk, 98 
et al. 1992) and recent electrophysiological studies have described potent depolarizing effects of 99 
SP and NKA on ARC Kiss1 neurons in the mouse (de Croft, et al. 2013) indicating that LH 100 
stimulation by these tachykinins involves, at least in part, a kisspeptin dependent mechanism. Of 101 
note, this study showed that, in vitro, the activation of kisspeptin neurons by NKB was completely 102 
diminished only when all three neurokinin receptor (NKR) subtype-selective antagonists were 103 
concomitantly applied in the in vitro bath (de Croft, et al. 2013). This is in line with studies carried 104 
out in vivo indicating that blockade of all 3 tachykinin receptors (but not each one of them 105 
individually) prevented the compensatory rise of LH after gonadectomy (GDX) in rats (Noritake, 106 
et al. 2011). Therefore, considerable cross reactivity exists between these receptor/ligand 107 
systems and each one of these neuropeptides is capable of eliciting responses from all three 108 
neurokinin receptors (Beaujouan, et al. 2000, Cascieri, et al. 1992, Gether, et al. 1993). In these 109 
studies, the affinities or EC50 values of each tachykinin for NK1R, NK2R, and NK3R, respectively, 110 
were reported as follows: SP_2nM, 2200nM, and 18000nM; NKA _ 16nM, 3nM, and 1300nM; and 111 
NKB_70nM, 25nM, and 4nM (Seabrook, et al. 1995). These data suggest a likely interaction of 112 
NKA with NK1R as well as NK2R, and of NKB with all 3 receptors, at relatively low concentrations. 113 
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Furthermore, it has been demonstrated in rats, that pulsatile LH secretion was suppressed by 114 
central administration of CS-003, an antagonist for all three NKRs, whereas administration of 115 
each NKR subtype-selective antagonist alone, had no effect (Noritake, et al. 2011). In this respect, 116 
several pieces of evidence will be discussed below that provide unequivocal evidence that other 117 
members of the tachykinin family, namely SP and NKA, all encoded by the TAC1 or Tac1 gene 118 
(Table 1), in humans and rodents respectively (Lasaga and Debeljuk 2011) are an important 119 
component of the integrated neuronal hypothalamic system that controls GnRH/LH secretion in 120 
mammals. 121 
The current model for the GnRH pulse generator. 122 
Kiss1 neurons are located primarily in two discrete hypothalamic nuclei: the arcuate nucleus 123 
(ARC) and the anteroventral periventricular nucleus (AVPV/PeN) in rodents (Clarkson, et al. 124 
2009) or the preoptic area in ruminants (Lehman, et al. 2010), monkeys (Luque, et al. 2011) and 125 
humans (Hrabovszky 2014). Compelling evidence suggests that Kiss1 neurons in the ARC 126 
mediate the negative feedback of sex steroids and Kiss1 expression is inhibited by estradiol (E2) 127 
and testosterone (T). By contrast, Kiss1 expression in the AVPV/PeN—almost exclusive to the 128 
female brain— is upregulated by E2 and mediate the positive feedback that leads to the female-129 
specific preovulatory GnRH/LH surge (Maeda, et al. 2007, Navarro, et al. 2004, Smith, et al. 130 
2005). Substantial in vivo and in vitro evidence points to the importance of a population of neurons 131 
located in the ARC of the hypothalamus in playing the role of the GnRH pulse generator. The 132 
notion originated from studies carried out in the ovariectomized (OVX) rhesus monkey, in which 133 
LH secretion was abolished by selective lesioning of the ARC (Plant, et al. 1978), and was further 134 
reinforced by findings that multiunit electrical activity (MUA) in the vicinity of ARC kiss1 neurons 135 
was tightly coupled LH pulses (Kawakami, et al. 1982, Ohkura, et al. 2009). In this context, Kiss1 136 
neurons in the ARC coexpress dynorphin (inhibitory) and NKB (stimulatory) referred to as KNDy 137 
neurons (Cheng, et al. 2010, Goodman, et al. 2013, Navarro 2012), which have been proposed 138 
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to act in a coordinated, reciprocal fashion to shape the pulsatile release of kisspeptin in the median 139 
eminence, which in turn induces corresponding intermittent GnRH discharges at this site (Keen, 140 
et al. 2008). This has since been demonstrated in a variety of mammals including mice (Navarro, 141 
et al. 2009), rats (Navarro, et al. 2011a), sheep (Goodman, et al. 2013), goats (Wakabayashi, et 142 
al. 2010) and monkeys (Ramaswamy, et al. 2010). In this model, NKB would stimulate kisspeptin 143 
release and dynorphin would then inhibit this release through autosynaptic loops, thus shaping a 144 
kisspeptin/GnRH/LH pulse (Keen, et al. 2008). This is supported by the anatomical findings that 145 
virtually all KNDy neurons express NK3R (Amstalden, et al. 2010, Navarro, et al. 2009, Navarro, 146 
et al. 2011b) and >90% express kappa-opioid receptor [KOR; (Weems, et al. 2016)]. Furthermore, 147 
KNDy cells are interconnected with NKB fibers within the ARC forming a tightly regulated network 148 
(Krajewski, et al. 2010, Lehman, et al. 2010, Rance and Bruce 1994). Indeed, a growing number 149 
of studies in multiple species from our lab and others support the ability of NKB -or the NKB 150 
receptor (NK3R) agonist senktide- to increase LH pulses (Goodman, et al. 2014, Grachev, et al. 151 
2012, Navarro 2013). This places the KNDy neurons as ideal candidates for the role of the GnRH 152 
pulse generator. However, more recently, several studies have provided evidence that other 153 
tachykinins, i.e., SP and NKA, merit further investigation as additional fundamental components 154 
of the current, KNDy-dominated, GnRH pulse generator model. Although no human mutations in 155 
the genes encoding SP and NKA (TAC1) or their receptors (TACR1 and TACR2, respectively; 156 
Table 1) have been correlated with reproductive disorders yet, both SP and NKA have been 157 
reported to stimulate the gonadotropic axis in several species (Arisawa, et al. 1990, de Croft, et 158 
al. 2013, Kalra, et al. 1992, Navarro, et al. 2015, Noritake, et al. 2011, Sahu and Kalra 1992) 159 
including men (Coiro, et al. 1992). It is therefore plausible to speculate that these tachykinins are 160 
involved in the central regulation of GnRH release and may be additional elements to the GnRH 161 
pulse generator.  162 
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Anatomical studies.  163 
The topographical identification of tachykinin ligands and their receptors has provided important 164 
insight in to the potential mechanisms of action of these systems for the control of GnRH/LH 165 
secretion. Several studies using in situ hybridization, immunohistochemistry and single-cell RT 166 
PCR for the detection of mRNA and protein of tachykinins and their receptors, as well as their 167 
morphological relationship to Kiss1 and GnRH neurons, have been carried out to date. However, 168 
important information, especially regarding the localization of receptors, across a large number of 169 
species, is still lacking.   170 
Distribution of SP and NKA in the hypothalamus and anatomical relationship with 171 
Kiss1 and GnRH neurons. 172 
Within the hypothalamus, the largest population of NKB immunoreactive cells has been detected 173 
in the ARC (and specifically in the middle to caudal aspects) with smaller numbers identified in 174 
the ME, POA, lateral septum, bed nucleus of the stria terminalis, amygdala and the 175 
paraventricular nucleus of rats, sheep and mice (Goubillon, et al. 2000, Navarro, et al. 2009, 176 
Rance and Young 1991). The ARC population has received most attention, as in this nucleus 177 
kisspeptin and NKB reside in the same cell (KNDy; (Goodman, et al. 2007, Navarro, et al. 2009), 178 
whereas, no instances of NKB and GnRH colocalization have been reported, although GnRH and 179 
NKB immunopositive fibers have been observed to interweave in the rat ME (Krajewski, et al. 180 
2005).  181 
In mice, Tac1 mRNA (encoding SP and NKA) has been mapped out in the brain of female mice 182 
using in situ hybridization (Navarro, et al. 2015). Within the hypothalamus, expression was found 183 
to be concentrated mainly in 2 regions: the ARC (especially the caudal aspect) and the 184 
ventromedial nucleus (VMN), in keeping with previous reports of SP immunoreactivity in rats, 185 
monkeys, and humans (Borsay, et al. 2014, Harlan, et al. 1989, Rance and Bruce 1994, Rance 186 
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and Young 1991, Ronnekleiv, et al. 1984, Tsuruo, et al. 1991, Yamano, et al. 1986). Studies 187 
employing immunohistochemical detection of SP also report a plethora of fibers that innervate the 188 
entire length of the ARC and the median eminence (ME) (Hrabovszky, et al. 2013, Kalil, et al. 189 
2015) which appear to surround the capillaries of the hypophyseal portal system indicating that 190 
SP may have the ability to act directly on the anterior pituitary (Kalil, et al. 2015).  191 
 Interestingly, even though the Tac2 (gene encoding NKB; Table 1) is known to be coexpressed 192 
within Kiss1 in the ARC of various species, including humans (Goodman, et al. 2007, Hrabovszky 193 
2014, Navarro, et al. 2009) the Tac1-positive neurons did not colocalize with Kiss1-positive 194 
neurons in the mouse [(Navarro, et al. 2015); Figure.1).  This is in agreement with equivalent 195 
investigations in the monkey (Kalil, et al. 2015) and rat (Rance and Bruce 1994) but contradict 196 
findings in the human that report approximately 65% of SP neurons in the ARC coexpress 197 
kisspeptin [conversely, 30% of Kiss1 neurons contain SP; (Hrabovszky, et al. 2013)]. The reason 198 
for this divergence is not known, however, it supports the notion for the existence of potential 199 
differences in the function of the tachykinin systems across species (Hrabovszky, et al. 2013, 200 
Kalil, et al. 2015, Navarro, et al. 2015). Nonetheless, the population of Tac1 neurons in the ARC 201 
of the mouse (Navarro, et al. 2015) and SP immunoreactive neurons and fibers in the monkey 202 
(Kalil, et al. 2015) appeared to be in close contact with Kiss1 neurons and fibers [and GnRH fibers 203 
as shown in postmenopausal women (Hrabovszky, et al. 2013)] in the ARC, presumably 204 
facilitating the interaction between all three neuronal populations.  Immunohistochemical analysis 205 
of NKA fiber colocalization with kisspeptin or GnRH afferents merits future investigation. Of note, 206 
Tac1 mRNA was not detected in the AVPV/PeN of mice (Figure. 1), the region in which the second 207 
population of Kiss1 neurons reside (Oakley, et al. 2009), however, data from other species is non-208 
existent.   209 
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Distribution of NK1R and NK2R in the hypothalamus and anatomical relationship 210 
with Kiss1 and GnRH neurons. 211 
Single cell RT-PCR analysis of the expression of all 3 tachykinin receptors (Tacr1, Tacr2, 212 
and Tacr3 mRNA; Table 1) in Kiss1 (ARC and AVPV/PeN) and GnRH neurons showed that 213 
almost half (~49%) of Kiss1 neurons in the ARC and over one-fourth (~27%) of Kiss1 neurons in 214 
the AVPV/PeN express Tacr1 mRNA, which is also present in a subset of GnRH neurons [~23%; 215 
(Navarro, et al. 2015)]. Tacr2, however, was absent from both populations of Kiss1 neurons and 216 
GnRH neurons (Navarro, et al. 2015). Finally, Tacr3 was confirmed to be present in all (100%) 217 
ARC Kiss1 neurons but minimally present (~10%) in AVPV/PeN Kiss1 neurons, as has been 218 
previously described in various species (Amstalden, et al. 2010, Navarro, et al. 2015, Navarro, et 219 
al. 2009). Of note, Tacr3 mRNA was also detected in a small subset of GnRH neurons [~11%; 220 
(Navarro, et al. 2015)] as has been previously been reported in the rat (16% of GnRH somata 221 
contained NK3R immunostaining) (Krajewski, et al. 2005). In addition, extensive colocalization 222 
between GnRH axons with NK3R positive fibers have been reported in the ME and organum 223 
vasculosum of the lamina terminalis of the rat (Krajewski, et al. 2005). Whether NK1R or NK2R 224 
is expressed in KNDy and/or GnRH neurons in other species is unknown. 225 
Taken together, these anatomical data allow us to postulate that SP can regulate GnRH secretion 226 
indirectly, via initial action on Kiss1 neurons, but also directly by acting on GnRH neurons, 227 
although functional evidence for this pathway is lacking. Furthermore, the existence of axo-axonic 228 
or axo-dendritic synapses between SP and Kiss1 or GnRH axons remains to be elucidated. In 229 
the human, where SP and kisspeptin have been shown to colocalize, autocrine/paracrine actions 230 
of SP on KNDy neurons are also probable (Hrabovszky, et al. 2013). Intriguingly, in the mouse, a 231 
subset of AVPV/PeN Kiss1 neurons are also receptive to SP actions (one fourth of these cells 232 
contain NK1R) and it is well known that this population is involved in the generation of the 233 
GnRH/LH surge (Oakley, et al. 2009). Therefore, a role for SP signaling in the shaping of the 234 
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GnRH surge is likely, but remains unexplored.  The action of NKA, on the other hand, remains 235 
largely unresolved, because Tacr2 has been identified in neither Kiss1 nor GnRH neurons, thus, 236 
suggesting the presence of unidentified intermediate upstream neurons [(Navarro, et al. 2015); 237 
Figure.1]. 238 
Sex steroid regulation of SP and NKA.  239 
All known cotransmitters present in ARC Kiss1 neurons (Kiss1, NKB, and dynorphin) are inhibited 240 
by sex steroids as part of their hypothesized role in the negative feedback upon GnRH release 241 
(Gottsch, et al. 2009, Navarro, et al. 2009). This also appears to be true for SP and NKA, as Tac1-242 
expressing neurons in the ARC and VMN of mice were downregulated by OVX and E2 treatment 243 
(Micevych, et al. 1988, Navarro, et al. 2015) and immunopositive SP protein in the ARC increased 244 
after gonadectomy (GND) in the male monkey (Kalil, et al. 2015). Furthermore, this effect 245 
appeared to be specific for these areas of the brain (Navarro, et al. 2015) and was not evident 246 
elsewhere. Similarly, SP mRNA increased in the hypothalamus of post- compared to pre-247 
menopausal women (Rance and Young 1991) and the content of SP in the ARC has been shown 248 
to increase after OVX in the rat (Tsuruo, et al. 1987). The results of all these studies suggest that 249 
downregulation of SP and NKA in hypothalamic neurons may mediate, at least in part, the 250 
negative feedback action of gonadal steroids on gonadotropin secretion. Indeed, earlier studies 251 
have demonstrated that a substantial population of SP immunoreactive cells located in the 252 
mediobasal hypothalamus of the rat are estrogen receptive (26.1% in the Arc and 42.9% in the 253 
VMN) (Akesson and Micevych 1988). Interestingly, immunohistochemical studies on human 254 
hypothalami have revealed that postmenopausal women have higher numbers of SP neurons 255 
and darker labeling than in age-matched men (Hrabovszky, et al. 2013). However, if this 256 
constitutes a sex difference in the expression of SP or it is a mere reflection of different levels of 257 
sex steroids, remains to be elucidated. In this context, an earlier report documents greater SP 258 
immunoreactivity in the medial amygdala of male compared to female rats (Micevych, et al. 1988), 259 
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an area which is also known for a greater Kiss1 population of cells in males versus females 260 
(Stephens, et al. 2016). However, the interaction between these two systems (SP and Kiss1 in 261 
the medial amygdala) has not yet been explored. Nonetheless, sex differences in the expression 262 
of SP or NKA require further characterization across multiple species. 263 
Regulation of LH release by tachykinins: sex steroid dependent 264 
action. 265 
Neurokinin B 266 
Most studies carried out to date looking into the effect of tachykinins on reproductive function 267 
have focused on the role of NKB, and less so on other members of the tachykinin family.  268 
Therefore, it is useful to compare findings from SP and NKA studies with those already carried 269 
out for NKB, as a synergistic action is highly probable. One thing that can be said about the 270 
stimulatory effect of NKB on LH release, is that it is less robust than that of kisspeptin, and 271 
inhibitory actions or null effects on LH secretion have also been documented, depending on the 272 
species and the sex steroid levels (Navarro, et al. 2011a, Ruiz-Pino, et al. 2012, Sandoval-273 
Guzman and Rance 2004). For instance, NKB induced significantly stimulatory LH responses in 274 
adult female rats and mice under physiological levels of sex steroids, whereas only adult intact 275 
male mice (but not rats) displayed LH responses to the same challenge (Navarro, et al. 2011b, 276 
Ruiz-Pino, et al. 2012). By contrast, predominant inhibitory effects of the selective NK3R agonist, 277 
senktide, have been reported in rodents with null or low sex steroids levels (Grachev, et al. 2012, 278 
Navarro, et al. 2015, Navarro, et al. 2011b), even though kisspeptins are known to stimulate 279 
gonadotropin secretion irrespective of the sex steroid milieu (Oakley, et al. 2009). From a 280 
mechanistic point of view, the inhibitory action of NKB on LH release appears to be opioid 281 
mediated, as has been shown by lack of LH inhibition by senktide in the presence of KOR agonist 282 
in rats (Kinsey-Jones, et al. 2012). In accordance, extracellular recordings from KNDy neurons 283 
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demonstrated that gonadal feedback (by both estrogen and dihydrotestosterone) attenuates the 284 
stimulatory effects of senktide on the firing rate of KNDy neurons while increasing the inhibitory 285 
effects of dynorphin by modulating the activation of NK3R and KOR (Ruka, et al. 2016). 286 
Interestingly, in the sheep, NKB/NK3R signaling may also be important in the generation of the 287 
preovulatory GnRH/LH surge. For example, intracerebroventricular (i.c.v) microinjections of 288 
senktide, in this species, results in a surge-like elevation of LH during the follicular but not the 289 
luteal phase of the ovine estrous cycle (Billings, et al. 2010, Porter, et al. 2014), replicating a 290 
potential dual effect of NKB, dependent on sex steroid levels, as observed in rodents (Navarro, 291 
et al. 2011a). These observations illustrate the complexity of the effects of NKB on the 292 
gonadotropic axis.  293 
 294 
Substance P 295 
To date, SP has largely been associated with processes unrelated to reproductive function, such 296 
as pain perception and inflammatory activity in the brain (De Felipe, et al. 1998) as well as with 297 
psychiatric disorders (Ebner and Singewald 2006). Even though SP was originally identified in 298 
the 1930’s (Lasaga and Debeljuk 2011) it is only now beginning to come in to the spotlight as a 299 
regulator of the reproductive axis. Few earlier studies aimed to investigate the effects of SP on 300 
the gonadotropic axis and report variable results (Table 2).  These include peripheral (i.v.) 301 
administration of SP for 1 hour in normal men, which induced a robust discharge of LH (Coiro, et 302 
al. 1992) and in OVX rats i.c.v specific antiserum against SP (anti-SP) decreased plasma LH, 303 
whereas synthetic SP injected i.c.v. or i.v. into OVX+E2 rats, stimulated LH release, via both routes 304 
of administration (Arisawa, et al. 1990). Other studies conducted by Kalra et al., in the 90’s (Kalra, 305 
et al. 1992) (Sahu and Kalra 1992) report null or inhibitory effects in intact and GND males, 306 
respectively, hinting at potential sex differences in the response to SP (Table 2). Further studies 307 
conducted on intact and OVX rabbits report that although the stimulatory effect of SP on LH is 308 
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sex steroid-independent, in the absence of ovarian steroids, SP is stimulatory only during the 309 
rising phase of an LH pulse (Traczyk, et al. 1992). Interest in SP has recently rekindled and 310 
studies in mice are pointing towards a clear stimulatory action on LH secretion, which appears to 311 
be independent of the sex steroid milieu Table 2; (Navarro, et al. 2015)]. In this study, the 312 
activation of NK1R with the i.c.v. administration of an NK1R specific agonist (GR73632) induced 313 
LH release in intact males, diestrous or OVX females and a 20-fold increase in OVX+E2 females 314 
(Navarro, et al. 2015). However, in rats that received the same agonist i.c.v., with the same dose, 315 
no alteration in LH levels was observed in either sex with intact gonads (Ruiz-Pino, et al. 2015) 316 
indicating a potential species difference. This notion is also supported by pharmacological data 317 
from ovary-intact anestrous ewes and OVX and OVX+E2 goats demonstrating that much higher 318 
doses of SP are needed to stimulate LH secretion compared to those needed with senktide 319 
(Goodman 2015, Yamamura, et al. 2015). 320 
In addition, a small body of literature has focused on the role of SP on the LH surge as well as 321 
sexual behavior. Intriguingly, a number of reports by Kerdelhué et al., in humans, monkeys and 322 
rats have shown variable results. Initially, a study carried out in cycling rats, investigated the 323 
effects of a subcutaneous injection of SP during proestrus, which led to a reduction of the LH 324 
surge amplitude (Duval, et al. 1996). Furthermore, this inhibitory effect was reversed with the 325 
simultaneous administration of SP and an NK1R antagonist (RP 67580) (Duval, et al. 1996). 326 
However, further studies showed a divergence in results using the NK1R antagonist (RPR 327 
100893) in OVX + E2 treated versus intact cycling monkeys. In the first study, the NK1R antagonist 328 
was administered in OVX + E2 treated monkeys causing a 50% enhancement of the LH surge 329 
(Kerdelhue, et al. 1997), supporting an inhibitory role of SP in the LH surge mechanism, similar 330 
to what was observed in the rat (Duval, et al. 1996). By contrast, the same antagonist 331 
administered during the ascending phase of plasma estradiol concentrations (prior to LH surge 332 
onset of cycling monkeys), resulted in a reduction in both the amplitude (41%) and the duration 333 
of the preovulatory LH surge (Kerdelhue, et al. 2000), providing evidence for a stimulatory role of 334 
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SP in this model. Additional detailed analysis of changes in plasma SP concentration, during the 335 
periovulatory period in women showed higher SP values during the day of the LH peak, the day 336 
of the descending phase and the day after the descending phase compared to all other stages in 337 
the menstrual cycle (Kerdelhue, et al. 2006). However, a similar study carried out in the cycling 338 
monkey, showed a decrease of plasma SP concentrations during the follicular phase leading up 339 
to the LH surge and an inverse relationship between SP and estradiol values during this time 340 
(Kerdelhue, et al. 2000). Thus, there appears to be a dual role for SP regarding the LH surge 341 
mechanism, as there have been inhibitory and stimulatory effects reported depending on species, 342 
sex steroid concentrations, as well as the timing of exposure relative to the LH surge onset. The 343 
mechanism by which SP plays a role in the events leading up to the LH surge is not clear; 344 
however, the fact that ~25% of Kiss1 neurons in the AVPV/PeN contain Tac1r provides some 345 
input on a potential involvement of SP in this process (Navarro, et al. 2015). In support of this 346 
notion, is the observation that SP stimulates LH to a greater extent in female compared to male 347 
mice (Navarro, et al. 2015), which are devoid of an AVPV/PeV Kiss1 population (Clarkson and 348 
Herbison 2006, Kauffman, et al. 2007).  349 
Precedent studies on the role of SP have also reported a potential action of SP on sexual 350 
behavior. The circuitry necessary for the expression of female sexual behavior, and specifically 351 
the estrogen-induced display of lordosis, originates from the ventro-lateral VMN (vl VMN) and 352 
projects to the midbrain periaqueductal central gray (Muntz, et al. 1980, Pfaff and Sakuma 1979, 353 
Yamanouchi, et al. 1990). A number of studies have suggested that SP may be an important 354 
participant in this circuitry, as SP injections in the periaqueductal central gray of OVX, estrogen-355 
primed rats produced a long-lasting increase of lordosis behavior (Dornan, et al. 1987) whereas 356 
SP antiserum injections in the same region inhibit the behavior (Dornan, et al. 1987). Interestingly, 357 
Fluoro-Gold injections into the dorsal midbrain labeled a large proportion (approximately 30%) of 358 
the vl VMN neurons immunoreactive for SP, in the guinea pig (Ricciardi and Blaustein 1994). 359 
Furthermore, pulsatile administration of estradiol, selectively induces the expression of 360 
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progesterone receptors in SP neurons located in this area (Olster and Blaustein 1992) and this 361 
process is necessary for the induction of lordosis (Rubin and Barfield 1983). Collectively, these 362 
results suggest that SP originating in the vl VMN may participate in the onset of lordosis behavior 363 
(Dornan, et al. 1990), however further detailed components of the anatomy and physiology of this 364 
neurocircuitry is missing.   365 
Neurokinin A 366 
By contrast, much less information is available on the other members of the tachykinin family such 367 
as NKA or its two elongated peptides, NPK and NPγ.  NKA is also encoded by the Tac1 gene in 368 
the rodent and preferentially binds to the NK2R (Beaujouan, et al. 2000). The NKA/NK2R 369 
signaling system appears to act through different regulatory mechanisms, than those identified 370 
for SP; however, it is noteworthy, that results to date have been a lot more consistent across 371 
species (Table 3). Central administration of the NK2R agonist, GR64349, displayed a NKB-like 372 
action in terms of LH release (the so called dual effect of senktide), showing inhibition in OVX 373 
mice but clear stimulation in OVX+E2 treated female and intact male mice (Navarro, et al. 2015). 374 
Similar results have been obtained by studies conducted in male and female rats (Kalra, et al. 375 
1992, Ruiz-Pino, et al. 2015, Sahu and Kalra 1992). These data indicate that NK2R and NK3R 376 
may converge on a common pathway to regulate GnRH release in a sex independent but sex 377 
steroid dependent manner making them ideal candidates to participate in the GnRH pulse 378 
generator (Table 3). In this aspect, pharmacological studies in goats (Yamamura, et al. 2015) and 379 
sheep (Goodman 2015), showed that the three NKR agonists possess the ability to induce MUA 380 
volleys and an increase in LH, respectively, albeit, with a significant difference in the efficacy to 381 
do so, as much higher concentrations of NK1R and NK2R agonists were required to have a similar 382 
effect as NKB agonist or senktide, respectively (Goodman 2015, Yamamura, et al. 2015). 383 
Therefore, a reasonable hypothesis could be that NKA (and potentially SP) participate in the pulse 384 
generator by amplifying the actions of NKB. However, this requires further investigation as 385 
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equivalent pulse studies are lacking in other species. Similar to what was previously suggested 386 
for the inhibitory action of NKB, the inhibitory action of NKA on LH release appears to also be 387 
opioid mediated, at least in the rat (Kalra, et al. 1992). It is plausible to speculate that there is a 388 
sex steroid dependent differential activation of the stimulatory (NK3R) or inhibitory receptor (KOR) 389 
after the administration of an NKA agonist in the presence versus absence of sex steroids, 390 
however, this remains to be proven.  391 
 392 
Tachykinins modulate the gonadotropic axis in a kisspeptin 393 
dependent manner. 394 
It is now well recognized that the stimulating effects of NKB on GnRH secretion are mediated 395 
primarily via initial kisspeptin stimulation. This has been demonstrated by studies that have shown 396 
that a) desensitization of the kisspeptin receptor blocks the stimulatory effect of senktide in 397 
monkeys (Ramaswamy, et al. 2011), b) senktide i.c.v administration induces c-Fos activation of 398 
kisspeptin cells in the ARC of rats (Navarro, et al. 2011a), c) as mentioned above, nearly all ARC 399 
kisspeptin cells contain NK3R receptors (Navarro, et al. 2009) and are excited by senktide/NKB 400 
(de Croft, et al. 2013), d) the stimulatory effect of senktide, is completely absent in Kiss1rKO mice 401 
(Garcia-Galiano, et al. 2012) and e) specific ablation of NK3R expressing neurons in the ARC of 402 
the rat impairs the postcastration rise in LH secretion (Mittelman-Smith, et al. 2012). The above 403 
studies clearly indicate the importance of NKB signaling on kisspeptin for GnRH stimulation. 404 
However, additional regulation of GnRH release at a different level, i.e. kisspeptin-independent 405 
action, cannot be excluded given the presence of NK1R and NK3R in a subset of GnRH neurons 406 
(Krajewski, et al. 2005, Navarro, et al. 2015)  and the reported kisspeptin-independent activation 407 
of GnRH neurons by NK3R agonists in vitro (Gaskins, et al. 2013). 408 
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In this regard, a similar mechanism of action appears to be employed by SP and NKA. Recent 409 
electrophysiological studies in a kisspeptin-green fluorescent protein mouse model, have 410 
described potent stimulatory actions of SP and NKA on ARC Kiss1 neurons (de Croft, et al. 2013). 411 
In addition, the administration of all individual tachykinin receptor agonists to mice lacking Kiss1r 412 
[Kiss1rKO mice] resulted in absent LH responses (Navarro, et al. 2015). This, taken together with 413 
the fact that 50% of KNDy neurons contain NK1R (Navarro, et al. 2015), suggests that SP is able 414 
to stimulate LH secretion by acting, at least in part, via a kisspeptin dependent mechanism 415 
(Figure. 1). Intriguingly, in a recent study on female mice, NK1R agonist (GR73632) elicited a 416 
greater LH response than that observed with an NK2R agonist [GR64349; (Navarro, et al. 2015)]. 417 
It is possible that the augmented stimulatory action of NK1R agonist on LH release is a reflection 418 
of the additional action of SP on both populations of Kiss1 neurons (ARC and AVPV/PeN) 419 
(Navarro, et al. 2015). In support of this hypothesis, the same exaggerated effect of NK1R agonist 420 
was not observed in male mice (Navarro, et al. 2015), which also lack an AVPV kiss1 neuronal 421 
population (Kauffman, et al. 2007, Smith, et al. 2005). Potential direct action on GnRH neurons 422 
however, cannot be overlooked, as at least in the mouse, a subset of GnRH neurons express SP 423 
(and NKB) receptors (Navarro, et al. 2015) and senktide can induce in vitro GnRH secretion in 424 
the ME in brain slices derived from Kiss1 knockout mice (Gaskins, et al. 2013). In this light, a very 425 
important question arises, which is also true for the action of NKB, as to which pathway is 426 
employed when (kisspeptin versus GnRH dependent pathways) and for what biological purpose. 427 
Potentially, as the majority of studies investigating the necessity of an intact Kiss1/Kiss1r signaling 428 
system in the stimulation of LH secretion by tachykinins have been carried out in the persistent 429 
hypogonadal state (primarily via the blockade of kiss1r; see above), it is plausible to speculate 430 
that the sex steroid milieu may be an important determining factor. Studies carried out with or 431 
without the presence of sex steroids and an absent Kiss1/Kiss1r system may be useful in this 432 
aspect.  The action of NKA, however, is less clear, because Tacr2 is not present in either Kiss1 433 
or GnRH neurons, while showing a kisspeptin-dependent action (Navarro, et al. 2015), thus 434 
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suggesting the presence of unidentified intermediate neurons upstream of Kiss1 neurons. 435 
Nonetheless, even though there are still major gaps in our knowledge regarding the potential 436 
mechanisms employed by each tachykinin, current data are overall, placing tachykinins in the 437 
spotlight as prime candidates for the neuromodulation of kisspeptin release. 438 
Despite substantial evidence for the hypothalamic action of tachykinins, we cannot ignore 439 
observations that suggest a direct action of SP and NKA in the pituitary. Firstly, SP fibers have 440 
been observed to surround hypophyseal portal blood capillary vessels in the ME in monkeys 441 
(Kalil, et al. 2015) and NKR’s have been shown to exist in pituitary cells in rats (Larsen, et al. 442 
1992) and sheep (Dupre, et al. 2010). Second, it has been reported that SP and NKA can 443 
stimulate LH secretion from cultured anterior pituitary cells derived from intact male rats (Kalra, 444 
et al. 1992) and hemi-pituitaries (Shamgochian and Leeman 1992), respectively. These findings 445 
however, are not consistent as the same was not observed in dispersed anterior pituitary cells 446 
harvested from female OVX+E2 rats (Arisawa, et al. 1990). Clearly, this pathway of action requires 447 
further investigation. For example, it would be interesting to evaluate whether LH secretion is 448 
stimulated after the peripheral administration of NKR agonists, but in the presence of a GnRH 449 
antagonist, to rule out any central effects on, or above, GnRH neurons that these agonists might 450 
exert by crossing the blood-brain barrier. This approach could potentially shed more light on the 451 
likelihood of a pituitary action of tachykinins.  452 
The role of tachykinins on puberty onset.  453 
The precise neuronal and endocrine mechanisms that determine the timing of puberty onset, and 454 
the subsequent achievement of reproductive capacity, remains one of the greatest unanswered 455 
questions in reproductive biology. To date, several factors from central and peripheral origins 456 
have been described to regulate the awakening of the gonadotropic axis (Ojeda and Lomniczi 457 
2014). At a neuroendocrine level, the prevailing view is that during the infantile and juvenile 458 
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periods, neurons secreting GnRH are subjected to persistent synaptic inhibition (Ojeda, et al. 459 
2010). When this inhibition is removed, GnRH secretion increases, which leads to puberty. 460 
However, it is recognized that a gain in numerous excitatory inputs to GnRH neurons is also 461 
indispensable (Ojeda and Lomniczi 2014). In this respect, both loss-of-function and gain-of-462 
function mutations in a growing number of neurotransmitters and their receptors have been 463 
described to severely impinge on the pubertal transition. As mentioned above, a number of 464 
studies have documented lack or delay of pubertal maturation in humans and mice bearing loss-465 
of-function mutations in KISS1/KISS1R or TAC3/TACR3 genes (de Roux, et al. 2003, Seminara, 466 
et al. 2003, Topaloglu, et al. 2012, Young, et al. 2010). In contrast, gain-of function mutations in 467 
KISS1R have been identified in association with central precocious puberty (Teles, et al. 2008). 468 
Therefore, kisspeptins are indispensable regulatory signals of GnRH release during puberty 469 
(Seminara, et al. 2003). In the same vein, the tachykinin NKB has been reported to stimulate 470 
kisspeptin prepubertally (Navarro, et al. 2012) and the expression of Tac2 increases before Kiss1 471 
(Gill, et al. 2012), suggesting a likely role of this tachykinin in the pubertal activation of kisspeptin-472 
GnRH secretion (Topaloglu, et al. 2009, Young, et al. 2010).  473 
The equivalent role of SP and NKA in the prepubertal increase of LH release and their contribution 474 
to the timing of puberty onset has only recently began to draw attention. A series of functional 475 
tests and genetic studies in the female mouse, have shown that SP/NK1R and NKA/NK2R 476 
signaling, appears to participate in the timing of puberty. This conclusion is derived from a study 477 
by (Simavli, et al. 2015) which has shown that 1) a selective NK1R agonist induces LH release in 478 
prepubertal females; 2) the expression of Tac1 and Tacr1 in the ARC is increased just before 479 
puberty compared to earlier or later stages of postnatal development; 3) repeated exposure to 480 
NK1R agonists prepubertally advances puberty onset, suggesting that the NK1R is already 481 
present and functional during this developmental period.  Furthermore, 4) Tac1KO female mice 482 
exhibit a significant delay in vaginal opening [defined as complete canalization of the vagina, an 483 
event that occurs with increased estrogen secretion (Caligioni 2009) and is therefore considered 484 
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an indirect maker for puberty onset] and delayed initiation of estrous cyclicity (Simavli, et al. 2015). 485 
This suggests that although E2 is produced by the ovaries in these mice, this alone may not be 486 
sufficient to trigger an LH surge during the initial phase post vaginal opening and this positive 487 
feedback may also be compromised during adulthood. Indeed, histological examination of the 488 
ovaries revealed fewer numbers of corpus lutea and antral follicles in Tac1 knockout mice. 489 
Similarly, in the rat, administration of NK1R and NK2R agonists was able to significantly increase 490 
LH release in prepubertal animals of both sexes, with NK2R agonist evoking a significantly greater 491 
response than that by NK1R agonist in both males and females (Ruiz-Pino, et al. 2015). By 492 
contrast castrated, juvenile and GnRH primed monkeys did not respond to an i.v. bolus 493 
administration of SP with an increase in LH secretion (Kalil, et al. 2015). The reason for this is not 494 
known however it may reflect a species difference. Interestingly, supporting the role of SP in the 495 
central control of puberty onset is the fact that higher SP levels detected in the brain of patients 496 
after traumatic brain injury (Gabrielian, et al. 2013, Vink and van den Heuvel 2010, Zacest, et al. 497 
2010) correlate with the significantly higher ratio of children displaying precocious puberty after 498 
traumatic brain injury (Blendonohy and Philip 1991, Kaulfers, et al. 2010). Overall, these data 499 
suggest a greater sensitivity to hypothalamic SP (and possibly NKA), at the time of puberty 500 
initiation, presumably contributing to an increase in GnRH pulses and activation of the 501 
gonadotropic axis; however, despite the compelling evidence for a central role of SP, we cannot 502 
rule out the possibility of actions of SP in other organs of the gonadotropic axis, such as the ovary 503 
(Debeljuk 2003, 2006). 504 
Concluding remarks 505 
Elucidating the neuronal mechanisms generating the GnRH pulses and surge is a prerequisite in 506 
advancing our understanding of reproductive function. This review intends to discuss the existing 507 
literature on the role of tachykinins as important components of this mechanism leading to GnRH 508 
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and therefore, LH secretion (model hypothesis; Figure 1). Overall, substantial evidence exists to 509 
support the hypothesis that tachykinins are indeed involved in the control of GnRH release, by 510 
modulating the firing of ARC KNDy neurons either directly (NKB and SP) or indirectly (NKA) to 511 
shape kisspeptin pulses (Figure 1). In addition, tachykinins, particularly SP may also act directly 512 
on GnRH and/or AVPV/PeN Kiss1 neurons to contribute to: a) the shaping of GnRH pulses, and/or 513 
b) the generation of the preovulatory LH surge. Many aspects of the physiology of the SP/NK1R, 514 
NKA/NK2R signaling systems in the context of reproduction, remain to be fully characterized. For 515 
instance, there appears to be a relative inconsistency in results between mice, rats, ruminants 516 
and monkeys in the LH response to the administration of tachykinins that may reflect anatomical 517 
and functional differences among species. In this regard, in humans SP is colocalized within a 518 
subset of KNDy neurons (Hrabovszky, et al. 2013) whereas this is not true for all other species 519 
studied to date (Kalil, et al. 2015, Navarro, et al. 2015, Rance and Bruce 1994, Rance and Young 520 
1991). Furthermore, in ruminants, a much larger dose of SP is required to stimulate LH release 521 
to a similar magnitude as an NKB agonist (Goodman 2015, Yamamura, et al. 2015), whereas in 522 
mice, similar doses of all individual NKR agonists can lead to an increase in LH (Navarro, et al. 523 
2015). However, as discussed, routes of administration, age (prepubertal versus postpubertal) 524 
and sex steroid status might be a determining factor in this aspect and must be taken in to 525 
account. Another important parameter that requires specific attention in future studies is the 526 
considerable crossreactivity that exists between these receptor/ligand systems determining the 527 
efficacy of tachykinin administration and it may be that although the three NKRs are involved in 528 
the GnRH pulse generation of KNDy neurons, the ratio of the contribution of each NKR varies 529 
among species and/or sexes. Nonetheless, this phenomenon may offer important advantages in 530 
the treatment of disorders caused by disruption of one specific system. For example, the reversal 531 
phenotype in reproductive viability observed in individuals with TAC3/TACR3 mutations (Gianetti, 532 
et al. 2010) may be due to compensation by the other tachykinin systems although this remains 533 
to be elucidated. Altogether, there is a clear need for a deeper understanding of the mechanism 534 
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of action of tachykinins. We must answer: a) whether all tachykinins participate in the generation 535 
of LH pulses, b) if there is compensation between tachykinins to exert this role and to what extent, 536 
c) whether the pathway (KNDy versus GnRH) of tachykinin action is governed by sex steroid 537 
levels and the biological role of this interaction , d) if the expression of tachykinin receptors in 538 
GnRH neurons changes (increases or decreases) in an estradiol dependent manner, e) the 539 
anatomical relationship of tachykinins and their receptors with kisspeptin and GnRH perikarya 540 
and fibers in other species, apart from the mouse, f) the sex and species differences in the 541 
response to tachykinins and the contribution of SP/NK1R signaling on AVPV/PeN Kiss1 neurons 542 
or GnRH for the occurrence of the GnRH/LH surge in the female. h) the mechanism and site of 543 
action of NKA, as well as the phenotype of the cells that contain NK2R, which appear to be 544 
surrogates for the indirect action of Tac1 on KNDy neurons. 545 
All of these unresolved questions are fundamental to understanding the mechanisms that govern 546 
GnRH release in mammals, and the outcome of studies such as these may prompt a change in 547 
the thinking of the current models of GnRH pulse generation. Moreover, expanding the current 548 
model will have tremendous clinical potential in humans, since there is a large number of disorders 549 
associated with dysregulation of GnRH release - e.g. delayed and precocious puberty, polycystic 550 
ovarian syndrome, hormone-dependent tumors - that could be treated in a more physiological 551 
and effective manner. 552 
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Figure legends. 562 
 563 
Figure 1. Schematic representation of a hypothalamic neuronal network comprising Kiss1 564 
neurons, GnRH neurons and Tac1 neurons in the mouse. Percentage data depicting the co-565 
expression of each receptor at each neuronal population as observed in studies carried out in 566 
mice using single cell RT-PCR (Navarro, et al. 2015). ARC Kiss1 neurons (KNDy neurons) are 567 
able to respond to NKB and half of them can also respond to SP. A subset of AVPV/PeN Kiss1 568 
neurons also expresses the receptor for SP (NK1R) and a small fraction of them also express 569 
NKB receptor (NK3R). In addition, GnRH neurons, which respond primarily to kisspeptin, express 570 
SP and NKB receptors in small numbers. Finally, NKA must act on yet unknown intermediate 571 
neurons to stimulate kisspeptin release. Note: the location of the receptors in the cell (soma vs 572 
terminals) in this model, as well as the location of NKA-responsive neurons, is merely 573 
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